Abstract
First of all, donation should be based on voluntary will and the donor should be healthy. A donor candidate should be fully informed about benefits and adverse effects to the donor and recipient after transplantation and the expected prognosis of the recipient. Japanese transplant law requires confirmation of voluntary will, fully consented form, and full understanding of the risks and benefits to the donor, and a psychologist should confirm it. A donor is chosen from relatives including spouses. Emotional relatives should be strictly assessed by ethical committees to avoid organ trade.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.
Kiuchi T, Harada H, Matsukawa H, Kasahara M, Inomata Y, Uemoto S, Asonuma K, Egawa H, Maruya E, Saji H, Tanaka K. One-way donor-recipient HLA-matching as a risk factor for graft-versus-host disease in living-related liver transplantation. Transpl Int. 1998;11 Suppl 1:S383–4.
Miyagawa-Hayashino A, Yoshizawa A, Uchida Y, Egawa H, Yurugi K, Masuda S, Minamiguchi S, Maekawa T, Uemoto S, Haga H. Progressive graft fibrosis and donor-specific HLA antibodies in pediatric late liver allografts. Liver Transpl. 2012;18(11):1333–42.
Egawa H. Minimizing the risks for living donors of right lobe liver grafts. Nat Rev Gastroenterol Hepatol. 2011;8(5):251–2.
Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, Egawa H, Fujita S, Hayashi M, Tanaka K. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation. 1999;67(2):321–7.
Kawasaki S, Makuuchi M, Ishizone S, Matsunami H, Terada M, Kawarazaki H. Liver regeneration in recipients and donors after transplantation. Lancet. 1992;339(8793):580–1.
Kasahara M, Fukuda A, Yokoyama S, Sato S, Tanaka H, Kuroda T, et al. Living donor liver transplantation with hyperreduced left lateral segments. J Pediatr Surg. 2008;43:1575–8.
Mizuta K, Yasuda Y, Egami S, Sanada Y, Wakiya T, Urahashi T, et al. Living donor liver transplantation for neonates using segment 2 monosegment graft. Am J Transplant. 2010;10:2547–52.
Iwasaki M, Takada Y, Hayashi M, Minamiguchi S, Haga H, Maetani Y, Fujii K, Kiuchi T, Tanaka K. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation. 2004;78(10):1501–5.
Egawa H, Teramukai S, Haga H, Tanabe M, Fukushima M, Shimazu M. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology. 2008;47(1):143–52.
Egawa H, Ohmori K, Haga H, Tsuji H, Yurugi K, Miyagawa-Hayashino A, et al. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation. Liver Transplant. 2007;13(4):579–88.
Ikegami T, Taketomi A, Yoshizumi H, Harada N, Iguchi T, Hashimoto N, et al. Rituximab, IVIG, and plasma exchange without graft local infusion treatment; a new protocol in ABO incompatible living donor liver transplantation. Transplantation. 2009;88:303–7.
Takayama T, Makuuchi M, Kubota K, Sano K, Harihara Y, Kawarasaki H. Living-related transplantation of left liver plus caudate lobe. J Am Coll Surg. 2000;190(5):635–8.
Sugawara Y, Makuuchi M, Imamura H, Kaneko J, Kokudo N. Outflow reconstruction in extended right liver grafts from living donors. Liver Transplant. 2003;9(3):306–9.
Ito T, Kiuchi T, Yamamoto H, Oike F, Ogura Y, Fujimoto Y, et al. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation. 2003;75(8):1313–7.
Ogura Y, Hori T, El Moghazy WM, Yoshizawa A, Oike F, Mori A, et al. Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before. Liver Transplant. 2010;16(6):718–28.
Uemoto S, Sugiyama K, Marusawa H, Inomata Y, Asonuma K, Egawa H, Kiuchi T, Miyake Y, Tanaka K, Chiba T. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation. 1998;65(4):494–9.
Asonuma K, Ohya Y, Isono K, Takeichi T, Yamamoto H, Lee KJ, Okumura K, Ando Y, Inomata Y. Current state of domino transplantation in Japan in terms of surgical procedures and de novo amyloid neuropathy. Amyloid. 2012;19 Suppl 1:75–7.
Tincani G, Hoti E, Andreani P, Ricca L, Pittau G, Vitale V, Blandin F, Adam R, Castaing D, Azoulay D. Operative risks of domino liver transplantation for the familial amyloid polyneuropathy liver donor and recipient: a double analysis. Am J Transplant. 2011;11(4):759–66.
The Japanese Liver Transplantation Society. Liver transplantation in Japan: registry by the japanese liver transplantation society. Ishoku. 2010;46:624–36.
Hashikura Y, Ichida T, Umeshita K, Kawasaki S, Mizokami M, Mochida S, Yanaga K, Monden M, Kiyosawa K, Japanese Liver Transplantation Society. Donor complications associated with living donor liver transplantation in Japan. Transplantation. 2009;88:110–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this chapter
Cite this chapter
Egawa, H. (2014). LD for Liver Transplantation. In: Asano, T., Fukushima, N., Kenmochi, T., Matsuno, N. (eds) Marginal Donors. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54484-5_12
Download citation
DOI: https://doi.org/10.1007/978-4-431-54484-5_12
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54483-8
Online ISBN: 978-4-431-54484-5
eBook Packages: MedicineMedicine (R0)